These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 2983688

  • 1. Difluoromethylornithine-induced amplification of ornithine decarboxylase genes in Ehrlich ascites carcinoma cells.
    Alhonen-Hongisto L, Kallio A, Sinervirta R, Seppänen P, Kontula KK, Jänne OA, Jänne J.
    Biochem Biophys Res Commun; 1985 Jan 31; 126(2):734-40. PubMed ID: 2983688
    [Abstract] [Full Text] [Related]

  • 2. Tumourigenicity, cell-surface glycoprotein changes and ornithine decarboxylase gene pattern in Ehrlich ascites-carcinoma cells.
    Alhonen-Hongisto L, Kallio A, Sinervirta R, Jänne OA, Gahmberg CG, Jänne J.
    Biochem J; 1985 Aug 01; 229(3):711-5. PubMed ID: 2996487
    [Abstract] [Full Text] [Related]

  • 3. Gene expression of ornithine decarboxylase in L1210 leukaemia cells exposed to DL-2-difluoromethylornithine in the presence of cadaverine.
    Alhonen-Hongisto L, Sinervirta R, Jänne OA, Jänne J.
    Biochem J; 1985 Dec 01; 232(2):605-7. PubMed ID: 3937520
    [Abstract] [Full Text] [Related]

  • 4. Ornithine decarboxylase inhibitors increase the cellular content of the enzyme: implications for translational regulation.
    Persson L, Oredsson SM, Anehus S, Heby O.
    Biochem Biophys Res Commun; 1985 Aug 30; 131(1):239-45. PubMed ID: 3929778
    [Abstract] [Full Text] [Related]

  • 5. Human myeloma cells acquire resistance to difluoromethylornithine by amplification of ornithine decarboxylase gene.
    Leinonen P, Alhonen-Hongisto L, Laine R, Jänne OA, Jänne J.
    Biochem J; 1987 Feb 15; 242(1):199-203. PubMed ID: 3109382
    [Abstract] [Full Text] [Related]

  • 6. Regulation of S-adenosylmethionine decarboxylase by polyamines in Ehrlich ascites-carcinoma cells grown in culture.
    Alhonen-Hongisto L.
    Biochem J; 1980 Sep 15; 190(3):747-54. PubMed ID: 6781485
    [Abstract] [Full Text] [Related]

  • 7. Polyamines in mycoplasmas and in mycoplasma-infected tumour cells.
    Alhonen-Hongisto L, Veijalainen P, Ek-Kommonen C, Jänne J.
    Biochem J; 1982 Jan 15; 202(1):267-70. PubMed ID: 6805470
    [Abstract] [Full Text] [Related]

  • 8. Translational regulation of mammalian ornithine decarboxylase by polyamines.
    Kahana C, Nathans D.
    J Biol Chem; 1985 Dec 15; 260(29):15390-3. PubMed ID: 3934157
    [Abstract] [Full Text] [Related]

  • 9. Human myeloma cells acquire resistance to difluoromethylornithine without overproducing ornithine decarboxylase.
    Alhonen-Hongisto L, Leinonen P, Laine R, Jänne J.
    Biochem Biophys Res Commun; 1987 Apr 14; 144(1):132-7. PubMed ID: 3107550
    [Abstract] [Full Text] [Related]

  • 10. Development of resistance to hydroxyurea during treatment of human myelogenous leukemia K562 cells with alpha-difluoromethylornithine as a result of coamplification of genes for ornithine decarboxylase and ribonucleotide reductase R2 subunit.
    Ask A, Persson L, Rehnholm A, Frostesjö L, Holm I, Heby O.
    Cancer Res; 1993 Nov 01; 53(21):5262-8. PubMed ID: 8221660
    [Abstract] [Full Text] [Related]

  • 11. Chinese hamster ovary cells resistant to alpha-difluoromethylornithine are overproducers of ornithine decarboxylase.
    Choi JH, Scheffler IE.
    J Biol Chem; 1983 Oct 25; 258(20):12601-8. PubMed ID: 6415054
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cadaverine supplementation during a chronic exposure to difluoromethylornithine allows an overexpression, but prevents gene amplification, of ornithine decarboxylase in L1210 mouse leukaemia cells.
    Alhonen-Hongisto L, Hirvonen A, Sinervirta R, Jänne J.
    Biochem J; 1987 Nov 01; 247(3):651-5. PubMed ID: 3122732
    [Abstract] [Full Text] [Related]

  • 14. Measurement of the number of ornithine decarboxylase molecules in rat and mouse tissues under various physiological conditions by binding of radiolabelled alpha-difluoromethylornithine.
    Seely JE, Pösö H, Pegg AE.
    Biochem J; 1982 Aug 15; 206(2):311-8. PubMed ID: 6816220
    [Abstract] [Full Text] [Related]

  • 15. Differential effects of difluoromethylornithine on basal and induced activity of cerebral ornithine decarboxylase and mRNA.
    Zawia NH, Mattia CJ, Bondy SC.
    Neuropharmacology; 1991 Apr 15; 30(4):337-43. PubMed ID: 1852267
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Inhibition of cell proliferation by DL-alpha-difluoromethylornithine, a catalytic irreversible inhibitor of ornithine decarboxylase.
    Oredsson S, Anehus S, Heby O.
    Acta Chem Scand B; 1980 Apr 15; 34(6):457-8. PubMed ID: 6781187
    [No Abstract] [Full Text] [Related]

  • 19. Measurement of the amount of ornithine decarboxylase in Saccharomyces cerevisiae and Saccharomyces uvarum by using alpha-[5-14C]difluoromethylornithine.
    Pösö H, Pegg AE.
    Biochim Biophys Acta; 1983 Sep 28; 747(3):209-14. PubMed ID: 6412757
    [Abstract] [Full Text] [Related]

  • 20. Ornithine decarboxylase in difluoromethylornithine-resistant mouse lymphoma cells. Two-dimensional gel analysis of synthesis and turnover.
    McConlogue L, Coffino P.
    J Biol Chem; 1983 Jul 10; 258(13):8384-8. PubMed ID: 6408089
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.